These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7605797)

  • 21. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution.
    Pereira FB; Goñi FM; Nieva JL
    FEBS Lett; 1995 Apr; 362(2):243-6. PubMed ID: 7720880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
    Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y
    Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A molecular model for membrane fusion based on solution studies of an amphiphilic peptide from HIV gp41.
    Fujii G; Horvath S; Woodward S; Eiserling F; Eisenberg D
    Protein Sci; 1992 Nov; 1(11):1454-64. PubMed ID: 1303764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
    Pereira FB; Goñi FM; Muga A; Nieva JL
    Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Membrane fusion induced by the HIV type 1 fusion peptide: modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds.
    Pereira FB; Goñi FM; Nieva JL
    AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1203-11. PubMed ID: 9310287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the ectodomain of the gp41 transmembrane envelope protein of human immunodeficiency virus type 1 in late steps of the membrane fusion process.
    Bär S; Alizon M
    J Virol; 2004 Jan; 78(2):811-20. PubMed ID: 14694113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conversion of an immunogenic human immunodeficiency virus (HIV) envelope synthetic peptide to a tolerogen in chimpanzees by the fusogenic domain of HIV gp41 envelope protein.
    Haynes BF; Arthur LO; Frost P; Matthews TJ; Langlois AJ; Palker TJ; Hart MK; Scearce RM; Jones DM; McDanal C
    J Exp Med; 1993 Mar; 177(3):717-27. PubMed ID: 7679708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the interaction of two peptides from the N terminus of the NHR domain of HIV-1 gp41 with phospholipid membranes.
    Moreno MR; Guillén J; Pérez-Berna AJ; Amorós D; Gómez AI; Bernabeu A; Villalaín J
    Biochemistry; 2007 Sep; 46(37):10572-84. PubMed ID: 17711304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.
    Jin BS; Ryu JR; Ahn K; Yu YG
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1797-804. PubMed ID: 11118065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
    Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
    Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of the inhibition capacity of an 18-mer peptide domain of GBV-C virus on gp41-FP HIV-1 activity.
    Haro I; Gómara MJ; Galatola R; Domènech O; Prat J; Girona V; Busquets MA
    Biochim Biophys Acta; 2011 Jun; 1808(6):1567-73. PubMed ID: 21377446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fusion of negatively-charged liposomes under the effect of peptides from the N-terminal fragment of the HIV-1 transmembrane protein].
    Terletskaia IaT; Trikash IO; Serdiuk ES; Andreev SM
    Biokhimiia; 1995 Oct; 60(10):1711-9. PubMed ID: 8555367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biophysical characterization and membrane interaction of the most membranotropic region of the HIV-1 gp41 endodomain.
    Moreno MR; Pérez-Berná AJ; Guillén J; Villalaín J
    Biochim Biophys Acta; 2008 May; 1778(5):1298-307. PubMed ID: 18230333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion.
    Melikyan GB; Egelhofer M; von Laer D
    J Virol; 2006 Apr; 80(7):3249-58. PubMed ID: 16537592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan.
    Moreno MR; Pascual R; Villalaín J
    Biochim Biophys Acta; 2004 Feb; 1661(1):97-105. PubMed ID: 14967479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis, enhanced fusogenicity, and solid state NMR measurements of cross-linked HIV-1 fusion peptides.
    Yang R; Yang J; Weliky DP
    Biochemistry; 2003 Apr; 42(12):3527-35. PubMed ID: 12653557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design of potent inhibitors of HIV-1 entry from the gp41 N-peptide region.
    Eckert DM; Kim PS
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11187-92. PubMed ID: 11572974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.
    Muñoz-Barroso I; Durell S; Sakaguchi K; Appella E; Blumenthal R
    J Cell Biol; 1998 Jan; 140(2):315-23. PubMed ID: 9442107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41.
    Joshi SB; Dutch RE; Lamb RA
    Virology; 1998 Aug; 248(1):20-34. PubMed ID: 9705252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creating an Artificial Tail Anchor as a Novel Strategy To Enhance the Potency of Peptide-Based HIV Fusion Inhibitors.
    Su S; Zhu Y; Ye S; Qi Q; Xia S; Ma Z; Yu F; Wang Q; Zhang R; Jiang S; Lu L
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.